Zymeworks
ZYME
43 hedge funds and large institutions have $121M invested in Zymeworks in 2018 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 5 closing their positions.
560% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 5
367% more capital invested
Capital invested by funds: $25.9M → $121M (+$94.8M)
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
187% more funds holding
Funds holding: 15 → 43 (+28)
23.32% more ownership
Funds ownership: 8.15% → 31.47% (+23%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$20.3M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$19.4M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$11.7M |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$9.61M |
| 5 |
PA
Perceptive Advisors
New York
|
+$6.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
-$5.36M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$638K |
| 3 |
SLG
Stanley-Laman Group
Berwyn,
Pennsylvania
|
-$439K |
| 4 |
Norges Bank
Oslo,
Norway
|
-$212K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$23K |
ZYME Hedge Fund Activity: Q2 2018 in Review
43 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2018, worth a combined $121M — up 367% from $25.9M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ZYME positions and 5 closed out — a net gain of 28 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $20.3M. The largest seller was PenderFund Capital Management, exiting entirely with an estimated $5.36M sold.
- 43 institutional investors held Zymeworks (ZYME) as of Q2 2018, up from 15 in Q1 2018.
- Funds reported $121M of Zymeworks stock for Q2 2018, up 367% quarter-over-quarter.
- 33 funds opened new Zymeworks positions in Q2 2018 and 5 closed out, a net change of +28 holders.
- The largest Zymeworks buyer in Q2 2018 was Baker Bros. Advisors, an estimated $20.3M added.
- The largest Zymeworks seller in Q2 2018 was PenderFund Capital Management, an estimated $5.36M sold.
Based on aggregated 13F filings for Q2 2018.